23,580 Views
•
07:39 min
•
June 28, 2019
DOI:
Transkrypcja
Automatically generated
Podsumowanie
Automatically generated
Cellular senescence is the key factor in the development of chronic age-related pathologies. Identification of therapeutics that target senescent cells show promise for extending healthy aging. Here, we present a novel assay to screen for the identification of senotherapeutics based on measurement of senescence associated β-Galactosidase activity in single cells.
Powiązane Filmy
09:58
RhoC GTPase Activation Assay
Powiązane Filmy
12347 Views
15:32
Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay
Powiązane Filmy
32011 Views
12:42
Fluorescence-microscopy Screening and Next-generation Sequencing: Useful Tools for the Identification of Genes Involved in Organelle Integrity
Powiązane Filmy
12241 Views
05:31
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
Powiązane Filmy
14289 Views
10:07
Identification of Post-translational Modifications of Plant Protein Complexes
Powiązane Filmy
23785 Views
09:19
RNA Catalyst as a Reporter for Screening Drugs against RNA Editing in Trypanosomes
Powiązane Filmy
8391 Views
09:44
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Powiązane Filmy
9313 Views
11:13
Identification of Kinase-substrate Pairs Using High Throughput Screening
Powiązane Filmy
8071 Views
12:36
Chromatin Immunoprecipitation Assay for the Identification of Arabidopsis Protein-DNA Interactions In Vivo
Powiązane Filmy
20233 Views
07:08
Identification of Novel Regulators of Plant Transpiration by Large-Scale Thermal Imaging Screening in Helianthus Annuus
Powiązane Filmy
5881 Views
Read Article
Cytuj ten artykuł
Fuhrmann-Stroissnigg, H., Santiago, F. E., Grassi, D., Ling, Y., Niedernhofer, L. J., Robbins, P. D. SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs. J. Vis. Exp. (148), e58133, doi:10.3791/58133 (2019).
Copy